BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale.
Cancers
Bracht, Jillian Wilhelmina Paulina JWP; Karachaliou, Niki N; Bivona, Trever T; Lanman, Richard B RB; Faull, Iris I; Nagy, Rebecca J RJ; Drozdowskyj, Ana A; Berenguer, Jordi J; Fernandez-Bruno, Manuel M; Molina-Vila, Miguel Angel MA; Rosell, Rafael R